Tech Company Financing Transactions
AviGenics Funding Round
AviGenics secured a $1.2 million funding round on 6/30/2008. Investors included Tullis Health Investors.
Transaction Overview
Company Name
Announced On
6/30/2008
Transaction Type
Venture Equity
Amount
$1,156,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
111 Riverbend Rd.
Athens, GA 30605
USA
Athens, GA 30605
USA
Phone
Website
Email Address
Overview
AviGenics, Inc. is a bio-pharmaceutical company developing improved and cost-efficient bio-therapeutics for the treatment of cancer, infectious diseases, organ-dysfunction, genetic disorders and autoimmune diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 6/30/2008: Provider HealthNet Services venture capital transaction
Next: 6/30/2008: Pivotal Systems venture capital transaction
Share this article
About Our VC Transactions Data
Our team works diligently to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs